[New insights into the pathophysiology of oedema in nephrotic syndrome]
- PMID: 21461007
- DOI: 10.3265/Nefrologia.pre2010.Nov.10724
[New insights into the pathophysiology of oedema in nephrotic syndrome]
Abstract
Oedema is a common clinical manifestation of nephrotic syndrome. However, the pathophysiological mechanism of sodium retention in nephrotic syndrome has been intensely debated for decades. Several clinical and experimental observations argue against the classic or "underfill" hypothesis of oedema formation in nephrotic syndrome. In many patients, oedema formation in nephrotic syndrome is due to the kidney being intrinsically unable to excrete salt and is unrelated to systemic factors (i.e. hypoalbuminaemia, decreased “effective” arterial blood volume, and secondary hyperaldosteronism). The cortical collecting duct is the nephron site of sodium retention in nephrotic syndrome. Activation of the epithelial sodium channel in the cortical collecting duct is responsible for sodium retention in nephrotic syndrome. In nephrotic syndrome, a defective glomerular filtration barrier allows the passage of proteolytic enzymes or their precursors, which have the ability to activate the epithelial sodium channel, thereby causing the the subsequent sodium retention and oedema.
Similar articles
-
The pathophysiology of edema formation in the nephrotic syndrome.Kidney Int. 2012 Sep;82(6):635-42. doi: 10.1038/ki.2012.180. Epub 2012 Jun 20. Kidney Int. 2012. PMID: 22718186 Review.
-
Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome.Kidney Int. 2018 Jan;93(1):159-172. doi: 10.1016/j.kint.2017.07.023. Epub 2017 Oct 14. Kidney Int. 2018. PMID: 29042083
-
Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F235-41. doi: 10.1152/ajprenal.00138.2015. Epub 2015 May 13. Am J Physiol Renal Physiol. 2015. PMID: 25972510
-
Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.Pediatr Nephrol. 2007 Dec;22(12):1983-90. doi: 10.1007/s00467-007-0521-3. Epub 2007 Jun 7. Pediatr Nephrol. 2007. PMID: 17554565 Free PMC article. Review.
-
Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome.J Cell Mol Med. 2019 Oct;23(10):6543-6553. doi: 10.1111/jcmm.14387. Epub 2019 Jul 31. J Cell Mol Med. 2019. PMID: 31368174 Free PMC article.
Cited by
-
Fluid balance concepts in medicine: Principles and practice.World J Nephrol. 2018 Jan 6;7(1):1-28. doi: 10.5527/wjn.v7.i1.1. World J Nephrol. 2018. PMID: 29359117 Free PMC article. Review.
-
Nutritional management of pediatric nephrotic syndrome regarding oxidative stress and antioxidant balance.Front Immunol. 2025 May 1;16:1542735. doi: 10.3389/fimmu.2025.1542735. eCollection 2025. Front Immunol. 2025. PMID: 40375997 Free PMC article. Review.
-
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality.Pediatr Nephrol. 2015 Jan;30(1):91-101. doi: 10.1007/s00467-014-2903-7. Epub 2014 Aug 17. Pediatr Nephrol. 2015. PMID: 25127916 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical